2m 2m 2m 2m 2m 2m 2m
ETON PHARM (ETON)
NASDAQ
$50.08+$0.05 (+0.11%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.4BMarket Cap
- 164.20%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ETON PHARM (ETON)
$50.08+$0.05 (+0.11%)
ETON | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $50.02 | ||
Change | -$0.89 (-1.77%) | ||
Open | $49.36 | ||
High | $50.48 | ||
Low | $48.74 | ||
Previous Close | $49.30 | ||
Volume | 483,690 | ||
30-Day Average Volume | 588,021 | ||
1-Week Change | -6.77% | ||
1-Month Change | -10.87% | ||
1-Year Change | 164.20% | ||
3-Year Change | 1,173.90% | ||
5-Year Change | 786.69% | ||
Fundamentals | |||
Shares Outstanding | 28.6M | ||
Total Assets | $115.8M | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $37.6M | ||
Net Income | $11.6M | ||
Free Cash Flow | $7.3M | ||
EBIT | $12.8M | ||
EBITDA | $14.2M | ||
Net Working Capital | $23.5M | ||
EPS | $0.35 | ||
Enterprise Value/EBITDA | 99 | ||
Enterprise Value/Revenue | 38 | ||
P/B | 30 | ||
P/E | 141 | ||
PEG | 0 | ||
Price/Free Cash Flow | 194 | ||
Price/Operating Cash Flow | 194 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue